
For ARB-class antihypertensive agents, we examined the association among initial prescription supply days (ie, 30- or 90-day) and adherence, hospitalization risk, and healthcare use.
For ARB-class antihypertensive agents, we examined the association among initial prescription supply days (ie, 30- or 90-day) and adherence, hospitalization risk, and healthcare use.
Published: June 12th 2025 | Updated: June 16th 2025
Published: June 10th 2025 | Updated: June 12th 2025
Published: June 2nd 2025 | Updated: June 11th 2025
Published: June 3rd 2025 | Updated: June 11th 2025
Published: May 30th 2025 | Updated: June 5th 2025
Published: April 18th 2025 | Updated: April 21st 2025